Shelter Pharma launches D3 cure capsules
This launch is part of the company's strategy to expand its nutraceutical portfolio
This launch is part of the company's strategy to expand its nutraceutical portfolio
The said certificate is valid for a period of 3 years and opens up the European and other markets for the company's products
Clinical trial enrollment has long been a bottleneck in drug development
This is also an important milestone in our product strategy for our expansion into the larger Latin American market
The plant can reach an annual capacity of 300 crore tablets and 90 crore capsules
The innovation -- UPM Circular Renewable Black -- is the world’s first bio-based, near-infrared (NIR) detectable, carbon-negative black
Subscribe To Our Newsletter & Stay Updated